Survival in a Contemporary, Real-World Cohort of Patients with Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: An Analysis from THAOSJonas Wixner, Nitasha Sarswat, Angela Dispenzieri et al.|Cardiology and Therapy|2025Cited by 4
Plasma Proteome Profiling Reveals Inflammation Markers and Tafamidis Effects in V30M Transthyretin PolyneuropathyKarina Nugroho, Jeffery W. Kelly, James J. Moresco et al.|International Journal of Molecular Sciences|2025Cited by 1